Last reviewed · How we verify
Plasma
At a glance
| Generic name | Plasma |
|---|---|
| Also known as | Convalescent Plasma COVID-19, Thawed Plasma, FFP and other approved plasma products |
| Sponsor | Jason Sperry |
| Modality | Biologic |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Blood Collection to Validated New Therapeutics Strategies Against Preeclampsia
- Enpowering Progression Risk of Cerebral Amyloid Angiopathy
- PRP Injection Into the Sacroiliac Joint After Ipsilateral THA: Effects on Early Recovery and Function (SIJ-THA Randomized Trial) (NA)
- Individualized Precision Isavuconazole Therapy Guided by PK/PD Principles for the Geriatric Population
- Leukapheresis to Obtain Plasma or Lymphocytes for Studies of HIV-infected Patients, Including Long-term Non-progressors
- Thumb Base Osteoarthritis: Ultrasound-guided Platelet-rich Plasma Versus Placebo Injection (PHASE2)
- Goal-Directed Hemostatic Resuscitation Trial in ACLF Induced Coagulopathy (NA)
- Apheresis and Specimen Collection Procedures to Obtain Plasma, Peripheral Blood Mononuclear Cells (PBMCs) and Other Specimens for Research Studies
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Plasma CI brief — competitive landscape report
- Plasma updates RSS · CI watch RSS
- Jason Sperry portfolio CI